What Is Mesothelioma Gene Therapy?
Mesothelioma gene therapy is an experimental treatment using genetic material to combat cancer when traditional methods fail. Approaches involve modifying patient cells or directly injecting therapeutic genes.
Status of Gene Therapies in the United States
Gene therapies are FDA-regulated, with a few approved for specific cancers like KYMRIAH® for leukemia and lymphoma.
How Gene Therapy Works for Mesothelioma
Gene therapy targets defective DNA in cancer cells by adding, sensitizing, or inducing cell death. It can also enhance the immune system’s cancer-fighting abilities. Approaches include immune-boosting genes, suicide genes, tumor suppressor genes, oncolytic viruses, and CAR T-cell therapy.
Eligibility for Mesothelioma Gene Therapy
Currently, clinical trials offer gene therapy options with varying eligibility criteria.
The Mesothelioma Gene Therapy Procedure and Experience
Gene therapy processes vary based on target cells, involving cell collection, modification, and reintroduction, often as part of combination treatment plans.
Survival in Mesothelioma Gene Therapy
Gene therapy can extend survival, but outcomes depend on factors like cancer type and patient health.
Gene Therapy Side Effects in Mesothelioma
Potential side effects include abdominal pain, fatigue, and fever. Risks include harm to healthy cells and immune reactions, necessitating discussion with oncologists.